New Issue: Science’s Impossible Questions. Read Now

Online Insomnia Therapy: A Dream Come True for Some Patients

Automated six-week interactive program comes amid a shortage of trained clinicians 

Join Our Community of Science Lovers!

Web-based therapy for insomnia is an effective option that could reach “previously unimaginable numbers of people,” researchers suggest.

Although cognitive behavior therapy for insomnia (CBT-I) is the first-line treatment for adults with chronic insomnia, there aren’t enough trained clinicians to deliver the treatment, according to Dr. Lee Ritterband of the University of Virginia School of Medicine in Charlottesville and colleagues.

To investigate whether web-based CBT-I is effective over the long term and might enable more people to benefit, the team randomly assigned 303 adults with chronic insomnia to a six-week automated, interactive and tailored web-based program (Sleep Healthy Using the Internet, or SHUTi, at www.myshuti.com) or an online, nontailored patient education program about insomnia.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


To be included in the study, participants had to take more than half an hour to fall asleep at the beginning of the night or be awake for more than half an hour after initially falling asleep at least three nights per week for at least six months; average 6.5 hours or less sleep time nightly; and experience significant stress or impaired functioning due to sleep disturbances. About half of participants also had at least one medical or psychiatric condition.

Most of the participants - 77 in the SHUTi group (51 percent) and 69 in the patient education group (46 percent) - had taken a sleep aid at least once.

The research team reports in JAMA Psychiatry that SHUTi was significantly more effective than the patient education program with respect to insomnia severity, delay until sleep onset and time awake after sleep onset. By one year, insomnia was no longer a problem for 57 percent of SHUTi participants versus 27 percent of those receiving education.

In addition, 70 percent of SHUTi participants had seen at least some improvement, compared to 43 percent of participants who received education.

Ritterband told Reuters Health that the online intervention is not intended to replace face-to-face CBT-I, “but rather to expand the availability and access (to CBT-I) to meet the needs of the millions of people.”

“Internet interventions are not for everyone . . . Those who prefer face-to-face therapy can still have that as a possibility if available, but those who are interested in a web-based program, or who do not otherwise have access to a CBT-I specialist in their region, could now have an option,” he said by email.

“Given the high prevalence of insomnia and its costly impact, from both a personal and economic perspective, it is critical that we continue to develop and evaluate methods of care that can make a meaningful public health impact,” he concluded.

Dr. Aric Prather of the University of California, San Francisco, coauthor of an accompanying editorial, told Reuters Health, “This study provides the strongest evidence to date that web-based CBT-I is efficacious for treating patients with insomnia, including those with some psychiatric and medical comorbidities. These findings further highlight how technology can help scale the disseminations of needed interventions.”

“There is often a misplaced concern that the Internet will replace the skilled clinician,” he said by email. “While web-based therapies, including SHUTi, will certainly increase the swath of individuals who receive treatment, there will likely always be a need for skilled therapists to meet the needs of patients who prefer face-to-face encounters or present with complex cases that require personalized care.”

Dr. Shelby Harris, director, Behavioral Sleep Medicine at the Sleep-Wake Disorders Center at Montefiore Hospital in New York City, pointed out that the authors of the study made sure in advance that participants did not have any untreated sleep disorders.

“Given that sleep apnea is extremely common,” she told Reuters Health by email, “it is important that patients make sure that any other sleep disorders are thoroughly evaluated (and treated if necessary) by a sleep physician.”

Harris concluded, “Early treatment is best, so this is a great resource for patients initially struggling with insomnia who may first present to a primary care office.”

Ritterband and three coauthors have equity ownership in BeHealth Solutions, which licensed the SHUTi program and platform from the University of Virginia.

SOURCE: bit.ly/2h3y6Uu and bit.ly/2gzJSSV JAMA Psychiatry, online November 30, 2016.

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe